Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant

被引:11
|
作者
Flisiak, Robert [1 ]
Zarebska-Michaluk, Dorota [2 ]
Dobrowolska, Krystyna [3 ]
Rorat, Marta [4 ,5 ]
Rogalska, Magdalena [1 ]
Krynska, Justyna Anna [1 ]
Moniuszko-Malinowska, Anna [6 ]
Czupryna, Piotr [6 ]
Kozielewicz, Dorota [7 ]
Jaroszewicz, Jerzy [8 ]
Sikorska, Katarzyna [9 ]
Bednarska, Agnieszka [10 ]
Piekarska, Anna [11 ]
Rzymski, Piotr [12 ]
机构
[1] Med Univ Bialystok, Dept Infect Dis & Hepatol, PL-15540 Bialystok, Poland
[2] Jan Kochanowski Univ, Dept Infect Dis & Allergol, PL-25317 Kielce, Poland
[3] Jan Kochanowski Univ, Coll Medicum, PL-25317 Kielce, Poland
[4] Wroclaw Med Univ, Dept Infect Dis & Hepatol, PL-51149 Wroclaw, Poland
[5] Wroclaw Med Univ, Dept Forens Med, PL-50367 Wroclaw, Poland
[6] Med Univ Bialystok, Dept Infect Dis & Neuroinfect, PL-15809 Bialystok, Poland
[7] Nicolaus Copernicus Univ, Fac Med, Dept Infect Dis & Hepatol, Coll Medicum Bydgoszcz, PL-87100 Torun, Poland
[8] Med Univ Silesia, Dept Infect Dis & Hepatol, PL-41902 Bytom, Poland
[9] Med Univ Gdansk, Fac Hlth Sci, Div Trop & Parasit Dis, PL-80210 Gdansk, Poland
[10] Med Univ Warsaw, Dept Adults Infect Dis, Hosp Infect Dis, PL-02091 Warsaw, Poland
[11] Med Univ Lodz, Dept Infect Dis & Hepatol, PL-90419 Lodz, Poland
[12] Poznan Univ Med Sci, Dept Environm Med, PL-60806 Poznan, Poland
关键词
SARS-CoV-2; COVID-19; Omicron; mortality; severity; INFECTION RECOMMENDATIONS; POLISH ASSOCIATION; EPIDEMIOLOGISTS; MANAGEMENT; OUTCOMES; WAVES;
D O I
10.3390/jcm12175572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aimed to compare the clinical picture of COVID-19 in the initial and later period of Omicron dominance and to identify populations still at risk. A retrospective comparison of the clinical data of 965 patients hospitalized during the early period of Omicron's dominance (EO, January-June 2022) with 897 patients from a later period (LO, July 2022-April 2023) from the SARSTer database was performed. Patients hospitalized during LO, compared to EO, were older, had a better clinical condition on admission, had a lower need for oxygen and mechanical ventilation, had less frequent lung involvement in imaging, and showed much faster clinical improvement. Moreover, the overall mortality during EO was 14%, higher than that in LO-9%. Despite the milder course of the disease, mortality exceeding 15% was similar in both groups among patients with lung involvement. The accumulation of risk factors such as an age of 60+, comorbidities, lung involvement, and oxygen saturation <90% resulted in a constant need for oxygen in 98% of patients, an 8% risk of mechanical ventilation, and a 30% mortality rate in the LO period. Multiple logistic regression revealed lower odds of death during the LO phase. Despite the milder course of infections caused by the currently dominant subvariants, COVID-19 prophylaxis is necessary in people over 60 years of age, especially those with comorbidities, and in the case of pneumonia and respiratory failure.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19
    Aiello, Tommaso Francesco
    Puerta-Alcalde, Pedro
    Chumbita, Mariana
    Monzo, Patricia
    Lopera, Carlos
    Hurtado, Juan Carlos
    Meira, Fernanda
    Mosquera, Mar
    Santos, Marta
    Fernandez-Pittol, Mariana
    Mensa, Josep
    Martinez, Jose Antonio
    Soriano, Alex
    Marcos, Ma Angeles
    Garcia-Vidal, Carolina
    JOURNAL OF INFECTION, 2022, 85 (05) : E152 - E154
  • [3] Post COVID-19 condition of the Omicron variant of SARS-CoV-2
    Morioka, S.
    Tsuzuki, S.
    Suzuki, M.
    Terada, M.
    Akashi, M.
    Osanai, Y.
    Kuge, C.
    Sanada, M.
    Tanaka, K.
    Maruki, T.
    Takahashi, K.
    Saito, S.
    Hayakawa, K.
    Teruya, K.
    Hojo, M.
    Ohmagari, N.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1546 - 1551
  • [4] Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
    Zhang, Jianguo
    Zhao, Daguo
    Hu, Jianhui
    Huang, Xing
    Gu, Qingqing
    Tao, Zhimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [5] Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
    Karim, Salim S. Abdool
    Karim, Quarraisha Abdool
    LANCET, 2021, 398 (10317): : 2126 - +
  • [6] Severity predictors of COVID-19 in SARS-CoV-2 variant, delta and omicron period; single center study
    Ogawa, Fumihiro
    Oi, Yasufumi
    Honzawa, Hiroshi
    Misawa, Naho
    Takeda, Tomoaki
    Kikuchi, Yushi M.
    Fukui, Ryosuke M.
    Tanaka, Katsushi M.
    Kano, Daiki
    Kato, Hideaki
    Abe, Takeru
    Takeuchi, Ichiro
    PLOS ONE, 2022, 17 (10):
  • [7] Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19
    Nicolas de Prost
    Etienne Audureau
    Nicholas Heming
    Elyanne Gault
    Tài Pham
    Amal Chaghouri
    Nina de Montmollin
    Guillaume Voiriot
    Laurence Morand-Joubert
    Adrien Joseph
    Marie-Laure Chaix
    Sébastien Préau
    Raphaël Favory
    Aurélie Guigon
    Charles-Edouard Luyt
    Sonia Burrel
    Julien Mayaux
    Stéphane Marot
    Damien Roux
    Diane Descamps
    Sylvie Meireles
    Frédéric Pène
    Flore Rozenberg
    Damien Contou
    Amandine Henry
    Stéphane Gaudry
    Ségolène Brichler
    Jean-François Timsit
    Antoine Kimmoun
    Cédric Hartard
    Louise-Marie Jandeaux
    Samira Fafi-Kremer
    Paul Gabarre
    Malo Emery
    Claudio Garcia-Sanchez
    Sébastien Jochmans
    Aurélia Pitsch
    Djillali Annane
    Elie Azoulay
    Armand Mekontso Dessap
    Christophe Rodriguez
    Jean-Michel Pawlotsky
    Slim Fourati
    Nature Communications, 13 (1)
  • [8] Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
    Yixuan Wang
    Yan Yao
    Qingfeng Zhang
    Hao Chen
    Yang He
    Ke Hu
    BMC Infectious Diseases, 24
  • [9] Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant
    Wang, Yixuan
    Yao, Yan
    Zhang, Qingfeng
    Chen, Hao
    He, Yang
    Hu, Ke
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [10] Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19
    de Prost, Nicolas
    Audureau, Etienne
    Heming, Nicholas
    Gault, Elyanne
    Pham, Tai
    Chaghouri, Amal
    de Montmollin, Nina
    Voiriot, Guillaume
    Morand-Joubert, Laurence
    Joseph, Adrien
    Chaix, Marie-Laure
    Preau, Sebastien
    Favory, Raphael
    Guigon, Aurelie
    Luyt, Charles-Edouard
    Burrel, Sonia
    Mayaux, Julien
    Marot, Stephane
    Roux, Damien
    Descamps, Diane
    Meireles, Sylvie
    Pene, Frederic
    Rozenberg, Flore
    Contou, Damien
    Henry, Amandine
    Gaudry, Stephane
    Brichler, Segolene
    Timsit, Jean-Francois
    Kimmoun, Antoine
    Hartard, Cedric
    Jandeaux, Louise-Marie
    Fafi-Kremer, Samira
    Gabarre, Paul
    Emery, Malo
    Garcia-Sanchez, Claudio
    Jochmans, Sebastien
    Pitsch, Aurelia
    Annane, Djillali
    Azoulay, Elie
    Dessap, Armand Mekontso
    Rodriguez, Christophe
    Pawlotsky, Jean-Michel
    Fourati, Slim
    NATURE COMMUNICATIONS, 2022, 13 (01)